Financial Resilience | Acadia Healthcare demonstrates robust performance with strong Q2 EBITDA beat and positive volume growth, projecting 10.4% year-over-year EBITDA growth for 2024 |
Expansion Strategies | Delve into Acadia's multifaceted growth plan, including facility expansions, de novo openings, and strategic partnerships, with a focus on the promising CTC market |
Market Challenges | Explore how Acadia navigates industry-wide pressures, particularly labor cost inflation and intense competition, while maintaining its market position |
Analyst Perspectives | Learn about the mixed but generally positive analyst sentiment, with price targets ranging from $83 to $94, reflecting Acadia's growth potential and market dynamics |
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Metrics to compare | ACHC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACHCPeersSector | |
---|---|---|---|---|
P/E Ratio | −1,016.3x | 23.0x | −0.6x | |
PEG Ratio | 9.83 | −0.16 | 0.00 | |
Price/Book | 1.8x | 3.4x | 2.6x | |
Price / LTM Sales | 1.7x | 1.1x | 3.3x | |
Upside (Analyst Target) | 62.9% | 12.6% | 44.5% | |
Fair Value Upside | Unlock | −7.1% | 6.0% | Unlock |